The Bottom Line

Hormonal acne in women — particularly linked to PCOS — presents differently from teenage acne, typically appearing on the lower face, jawline, and chin. It's driven by excess androgens that stimulate oil production and inflammation. Standard acne treatments often fail because they don't address the hormonal root cause. Anti-androgen therapy (spironolactone, oral contraceptives) combined with topical treatments produces the best long-term results.

What Makes Hormonal Acne Different

Hormonal acne in adult women has distinct features:

  • Location: Lower face — jawline, chin, neck, and around the mouth. This "U-zone" distribution contrasts with the T-zone (forehead, nose) pattern typical of teenage acne.
  • Type of lesions: Deep, tender, cystic nodules that don't come to a head easily. Often painful and slow to resolve.
  • Timing: Flares before menstruation (premenstrual acne), during ovulation, or during periods of stress. May worsen around the late luteal phase when progesterone and androgens are relatively elevated.
  • Resistance to standard treatments: Topical retinoids and benzoyl peroxide alone often provide incomplete improvement.
  • Age: Persists or begins in the 20s-40s, well past typical teenage acne years.

The PCOS-Acne Connection

PCOS affects 5-10% of women and is the most common endocrine disorder in women of reproductive age. Its hallmark is excess androgen production, which directly drives acne through:

  • Increased sebum production (oilier skin)
  • Abnormal follicular keratinization (clogged pores)
  • Bacterial proliferation in blocked follicles
  • Enhanced inflammatory response

About 30% of women with PCOS have acne as a presenting symptom. Other signs that your acne might be PCOS-related include: irregular periods, hirsutism (unwanted facial/body hair), weight gain (especially around the abdomen), and thinning scalp hair.

Treatment Approach

Hormonal therapy (first-line for hormonal acne):

  • Spironolactone (50-200mg daily): Anti-androgen that blocks testosterone at the skin level. Studies show 66-100% improvement in acne. Takes 3-6 months. Requires contraception.
  • Combined oral contraceptives: Suppress ovarian androgens and raise SHBG. Best with anti-androgenic progestins (drospirenone, cyproterone acetate). FDA-approved for acne.
  • Combination therapy: Spironolactone + birth control pill is the most effective hormonal approach for severe hormonal acne.

Topical treatments (adjunctive):

  • Retinoids (tretinoin, adapalene): Prevent clogged pores, reduce inflammation
  • Benzoyl peroxide: Kills acne bacteria without causing resistance
  • Azelaic acid (15-20%): Anti-inflammatory, anti-bacterial, and helps with post-acne dark marks

For PCOS specifically:

  • Metformin: Improves insulin resistance, which in turn reduces androgen production. May modestly help acne as a secondary benefit.
  • Lifestyle modifications: Weight loss of 5-10% in overweight women with PCOS can reduce androgens by 30-40%.
  • Low-glycemic diet: Reduces insulin-driven androgen production.

Frequently Asked Questions

Should I get my hormones tested?

Yes, if you have signs of hormonal excess (irregular periods, hirsutism, hair thinning) or if standard acne treatments aren't working. Key tests: total and free testosterone, DHEA-S, and possibly fasting insulin, glucose, and lipid panel for PCOS screening.

Why don't antibiotics work well for hormonal acne?

Antibiotics reduce bacteria and inflammation but don't address the hormonal driver — excess androgen stimulation of oil glands. This is why hormonal acne often returns when antibiotics are stopped. Anti-androgen therapy addresses the root cause.

How long before hormonal treatments work?

Spironolactone: 3-6 months for significant improvement. Birth control pills: 2-3 cycles for initial improvement, 6 months for full effect. This requires patience, but the results are more lasting than antibiotics because you're treating the underlying cause.

  1. Tan AU, et al. "A review of diagnosis and treatment of acne in adult female patients." International Journal of Women's Dermatology. 2018;4(2):56-71.
  2. Azziz R, et al. "Polycystic ovary syndrome." Nature Reviews Disease Primers. 2016;2:16057.
  3. Kim GK, Del Rosso JQ. "Oral spironolactone in post-teenage female patients with acne vulgaris." Journal of Clinical and Aesthetic Dermatology. 2012;5(3):37-50.